ImmuneBridge
PrivateLast Round
Seed
Mar 24, 2026
Total Funding Raised
$19.7M
Company Overview
ImmuneBridge is a biotechnology company specializing in allogeneic immunotherapies that enhance the body's own healing capabilities by expanding cord blood-derived immune stem cells to create a reliable and versatile source for cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneBridge Comps
Public and private peers based on sector, stage, and business model.
ImmuneBridge Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 24, 2026 | ||||
| Seed | Apr 11, 2023 |
ImmuneBridge Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | Seed |
| NFX | Seed |
| One Way Ventures | Seed |
| Gaingels | Seed |
| M Ventures | Seed |
| T.Rx Capital | Seed |
| Healthspan Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Dr. Rui Tostoes appointed as new CTO.
- Mar 24, 2026
Raised $8 million in a seed funding round.
ImmuneBridge Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmuneBridge's valuation, stock price, and market status.
